ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ODD ODDITY Tech Ltd.

Closed 04-02 16:00:00 EDT

13.86

+0.46

+3.43%

盘后13.86

+0.000.00%

19:42 EDT

High13.91	Low13.19	Vol990.19K
Open13.33	D1 Closing13.40	Amplitude5.34%
Mkt Cap785.26M	Tradable Cap542.85M	Total Shares56.66M
T/O13.57M	T/O Rate2.53%	Tradable Shares39.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":13.86,"timestamp":1775160000000,"preClose":13.4,"halted":0,"volume":990190,"hourTrading":{"tag":"盘后","latestPrice":13.86,"preClose":13.86,"latestTime":"19:42 EDT","volume":7666,"amount":106212.7,"timestamp":1775173332142,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.034328358208955155,"floatShares":39166500,"shares":56656685,"eps":1.791771,"marketStatus":"Closed","change":0.46,"latestTime":"04-02 16:00:00 EDT","open":13.33,"high":13.905,"low":13.19,"amount":13573339.35447,"amplitude":0.053358,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.791771,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":5,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":13.4,"preHourTrading":{"tag":"盘前","latestPrice":13.1,"preClose":13.4,"latestTime":"09:27 EDT","volume":374,"amount":4900.250102,"timestamp":1775136470077,"change":-0.3,"changeRate":-0.022388,"amplitude":0.026119},"postHourTrading":{"tag":"盘后","latestPrice":13.86,"preClose":13.86,"latestTime":"19:42 EDT","volume":7666,"amount":106212.7,"timestamp":1775173332142,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.773004,"impliedVol":0.9727,"impliedVolPercentile":0.9044},"requestUrl":"/m/hq/s/ODD/tweets","defaultTab":"tweets","newsList":[{"id":"2623343315","title":"Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2623343315","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623343315?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:45","pubTimestamp":1774874700,"startTime":"0","endTime":"0","summary":"– Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA submission and planned commercial launch –– Onboarded Chief Medical","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264634/0/en/Immix-Biopharma-Announces-Enrollment-Completion-of-BLA-Enabling-Relapsed-Refractory-AL-Amyloidosis-Trial-NEXICART-2-and-Upcoming-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AL","IE00B19Z6F94.USD","BK4588","IE0009354923.USD","BK4230","LABU","ODD","BK4572","BK4183","LU1169590202.USD","BK4585","IE0034390439.USD","LU1169589451.USD","BK4022","CAR","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311997","title":"Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311997","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311997?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:05","pubTimestamp":1774868700,"startTime":"0","endTime":"0","summary":"under review by U.S. Food and Drug Administration  with a. Prescription Drug User Fee Act  target action date of June 29,-- Commercial readiness activities ongoing in anticipation of potential. securities totaled $54.9 million, with expected runway into 2027. \"This year is shaping up to be pivotal for Unicycive, underscored by the U.S. Food and Drug Administration's acceptance of our New Drug Application resubmission for OLC and the potential for approval and launch later this year,\" said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. \"With hyperphosphatemia still uncontrolled in nearly 75% of U.S. patients with chronic kidney disease undergoing dialysis, OLC, if approved, has the potential to offer a meaningful new treatment option characterized by a differentiated clinical profile and reduced pill burden compared to currently available phosphate binders.\". resubmission of its NDA for OLC, an investigational oral phosphate binder. launch of OLC later this year, the Company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU2237443465.HKD","LU1363072403.SGD","BK4539","LU2237443978.SGD","CMC","LU0971096721.USD","IE00BFXG1179.USD","LU2237443382.USD","LU0267386448.USD","LU2237443622.USD","UNCY","LU0149725797.USD","LU2237443549.SGD","BK4006","IE00B1BXHZ80.USD","LU0882574139.USD","LU2746668461.USD","LU2746668974.SGD","LU2237443895.HKD","IE00BZ1G4Q59.USD","LU0170899867.USD","BK4588","BK4585","IE0009354923.USD","ODD","LABU","BK4183","BK4139","IE00BHPRN162.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622874140","title":"ODDITY Tech Is Maintained at Neutral by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622874140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622874140?lang=en_us&edition=fundamental","pubTime":"2026-03-28 01:36","pubTimestamp":1774632960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 13:36 ET (17:36 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622009503","title":"Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2622009503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622009503?lang=en_us&edition=fundamental","pubTime":"2026-03-26 02:08","pubTimestamp":1774462113,"startTime":"0","endTime":"0","summary":"Oddity Tech (ODD) told investors its AI-driven beauty platform was delivering strong growth and profitability. But behind the scenes, something was...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/oddity-tech-faces-securities-lawsuit-after-stock-drops-nearly-50-on-advertising-disruption-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/oddity-tech-faces-securities-lawsuit-after-stock-drops-nearly-50-on-advertising-disruption-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AI","BK4551","BK4543","BK4528","BK4588","AIPO","AIYY","AGIX","BK4585","BK4183","IE0009354923.USD","BK4587","ODD","BK4023","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622013950","title":"Oddity Tech director Michael Farello files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622013950","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622013950?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:27","pubTimestamp":1774384050,"startTime":"0","endTime":"0","summary":"Oddity director Michael Farello filed an initial Form 3 reporting direct ownership of 57,143 Class A ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLQkVpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BK4183","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167521893","title":"Key Corporate Announcements Summary for March 24 Evening","url":"https://stock-news.laohu8.com/highlight/detail?id=1167521893","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167521893?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:31","pubTimestamp":1774351864,"startTime":"0","endTime":"0","summary":"Jiuzhitong announced that its invested company, GALAXIS TECH Group Co., Ltd., was listed on the Main Board of the Hong Kong Stock Exchange on March 24. The company's investment cost was 26.6 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02729","BK4183","PID","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621722962","title":"Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2621722962","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621722962?lang=en_us&edition=fundamental","pubTime":"2026-03-23 14:02","pubTimestamp":1774245720,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 23, 2026 /PRNewswire/ -- Belief BioMed  and Grand Life Sciences Group Co., Ltd.  today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life Sciences the rights to commercialize its investigational product, BBM-H803, in Mainland China, Hong Kong China, Macau China, and Taiwan China. The collaboration underscores the shared commitment of both sides to leverage their respective strengths and resources in their respective fields,to accelerate the commercialization process of the product,help hemophilia A patients access innovative treatment option, and jointly promote the development of the gene therapy industry. The agreement was signed by Xiao Xiao, Co-founder, Chairman and CSO of Belief BioMed, and Zenghui, Feng, Chairman of Grand Life Sciences.Signing Ceremony for the Exclusive Commercial Collaboration Between Belief BioMed and Grand Life Sciences . About Hemophilia AHemophilia A is a genetic disorder caused by the def","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2939687/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2939687/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/belief-biomed-and-grand-life-sciences-announced-exclusive-commercial-partnership-in-the-field-of-hemophilia-a-bringing-innovative-gene-therapy-to-chinese-patients-302721797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","IE0009354923.USD","ODD","BK4183","IND.AU","BK7095","BLA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621757774","title":"Oddity Tech Director Lilach Payorski Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621757774","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621757774?lang=en_us&edition=fundamental","pubTime":"2026-03-21 07:10","pubTimestamp":1774048222,"startTime":"0","endTime":"0","summary":"Oddity director Lilach Payorski reported direct ownership of 10,917 Class A ordinary shares in an initial Form 3 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL74Smjs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621575779","title":"Oddity Tech Ltd. director Cheresniya Ohad files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621575779","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621575779?lang=en_us&edition=fundamental","pubTime":"2026-03-21 07:09","pubTimestamp":1774048142,"startTime":"0","endTime":"0","summary":"Oddity director Cheresniya Ohad filed an initial Form 3 reporting 9,961 Class A ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL4Fvf1f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621757222","title":"Oddity Tech Ltd. CTO Niv Price Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2621757222","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621757222?lang=en_us&edition=fundamental","pubTime":"2026-03-21 07:04","pubTimestamp":1774047889,"startTime":"0","endTime":"0","summary":"Oddity CTO Niv Price filed an initial beneficial ownership statement reporting 41,227 Class A ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL8QstWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620896241","title":"Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2620896241","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620896241?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:27","pubTimestamp":1773916020,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed  today announced that BBM-H901 , has been officially approved by the Pharmaceutical Administration Bureau of Macao Special Administrative Region of China for the treatment of adult patients with moderate to severe hemophilia B . This product is developed and manufactured by BBM, and Takeda China is responsible for its commercialization in mainland China, Hong Kong, China and Macao, China. Following its approval in mainland China in April 2025 as the country's first gene therapy for hemophilia B, [1] the recent approval of BBM-H901 in Macao, China, not only addresses the previously unmet medical need for such treatment in the region but also marks a crucial step in accelerating the global availability of this breakthrough gene therapy.BBM-H901 is a gene therapy drug based on a recombinant adeno-associated virus  vector. It can precisely deliver the high-activity FIX gene into the liver cells of patients, enabling the sustained and h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/belief-biomed-announced-bbm-h901-dalnacogene-ponparvovec-injection-chinas-first-hemophilia-b-gene-therapy-was-officially-approved-in-macao-china-302718633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","LU0053671581.USD","ABR","ABR.AU","BK7129","LU2463526074.USD","ODD","BK7095","ASH.AU","LU0054578231.USD","EMA","LU0963586101.USD","ASH","ATMP","EMA.AU","BK4567","BLA.AU","BK4110","BK4129","IE0009354923.USD","BK4183","BK7057","BK7504","FIX","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620219955","title":"ODDITY Tech’s Exchangeable Notes Raise Dilution Risks and May Fuel Short Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2620219955","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620219955?lang=en_us&edition=fundamental","pubTime":"2026-03-19 14:01","pubTimestamp":1773900070,"startTime":"0","endTime":"0","summary":"ODDITY Tech Ltd. Class A (ODD) has disclosed a new risk, in the Debt & Financing category. The analyst notes that exchanges of ODDITY Tech Ltd. Cla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oddity-techs-exchangeable-notes-raise-dilution-risks-and-may-fuel-short-selling-pressure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oddity-techs-exchangeable-notes-raise-dilution-risks-and-may-fuel-short-selling-pressure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620291188","title":"Oddity Tech Ltd. files initial beneficial ownership statement for Chief Product Officer Shiran Holtzman-Erel","url":"https://stock-news.laohu8.com/highlight/detail?id=2620291188","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620291188?lang=en_us&edition=fundamental","pubTime":"2026-03-19 08:41","pubTimestamp":1773880899,"startTime":"0","endTime":"0","summary":"Oddity Tech reported an initial statement of beneficial ownership for Shiran Holtzman-Erel. Holtzman-Erel is a director and Chief Product Officer. The filing reported a performance stock option covering 1,095,256 Class A ordinary shares. The option has an exercise price of USD 27.74 and an expiration date of June 21, 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL8cj43V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BK4183","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620299824","title":"Oddity Tech Ltd. CFO Lindsay Drucker Mann Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620299824","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620299824?lang=en_us&edition=fundamental","pubTime":"2026-03-19 08:08","pubTimestamp":1773878911,"startTime":"0","endTime":"0","summary":"Oddity Tech reported an initial statement of beneficial ownership by Lindsay Drucker Mann, its global chief financial officer. Drucker Mann reported direct ownership of 34,729 Class A ordinary shares. Drucker Mann also reported stock options covering 426,840 Class A ordinary shares at an exercise price of USD 9.39. The filing also listed stock options covering 717,876 shares at an exercise price of USD 13.93. It also reported restricted stock units covering 0.86 million Class A ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL3vkG4M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620408080","title":"Oddity Tech FY2025 net revenue rose 25.2% to USD 809.84 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620408080","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620408080?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:21","pubTimestamp":1773778902,"startTime":"0","endTime":"0","summary":"Oddity published its annual report on Form 20-F for the fiscal year ended Dec. 31, 2025, reporting net revenue of USD 809.84 million, up 25.2%. Net income was USD 110.75 million, while operating income was USD 118.77 million. Adjusted EBITDA rose 8.6% to USD 163.35 million, and adjusted EBITDA margin was 20.2%. The company said it has experienced a significant increase in customer acquisition costs that is adversely impacting revenue and margins, and it does not expect to achieve its long-term targets while those costs remain elevated. Oddity ended the year with USD 776 million of cash and cash equivalents, restricted cash, short-term deposits and marketable securities, and said it believes existing liquidity and positive operating cash flows will be sufficient for at least the next 12 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL5D4yfV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620470467","title":"Pomerantz files securities class action against Oddity Tech Ltd. over alleged misleading statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470467","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470467?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:46","pubTimestamp":1773776766,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against Oddity and certain officers in the U.S. District Court for the Southern District of New York under docket 26-cv-02046. The suit covers investors who purchased or acquired Oddity securities between Feb. 26, 2025 and Feb. 24, 2026. The complaint alleges the company misled investors about the impact of an algorithm change by its largest advertising partner that diverted ads to lower-quality auctions at higher costs, increasing customer acquisition costs. Oddity disclosed the issue in connection with its results for the fourth quarter and full year ended Dec. 31, 2025, and said it expected first-quarter 2026 revenue to decline about 30% year over year. Oddity shares fell $14.28, or 49.21%, to $14.74 on Feb. 25, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL7Fx4zp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU2210150020.SGD","BK4588","SG9999014039.USD","IE00BN0W2T93.GBP","ODD","IE0009354923.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4112","BK4183","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620646759","title":"Class Action Lawsuit Targets Oddity Tech Over Alleged Securities Law Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2620646759","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620646759?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:01","pubTimestamp":1773676861,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Oddity and certain officers, alleging violations of federal securities laws. The suit covers investors who bought or acquired Oddity securities between February 26, 2025 and February 24, 2026. The complaint alleges the company did not disclose that an algorithm change by its largest advertising partner diverted ads to lower-quality auctions at abnormally high costs. It also alleges customer acquisition costs rose significantly, and that Oddity’s public statements about its digital operating model and market position were materially false or misleading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL2p7DTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","LU2095319765.USD","BK4183","SG9999014013.SGD","IE00BGHQF748.EUR","IE0009354923.USD","NDAQ","LU2210150020.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4112","BK4585","ODD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619635414","title":"Oddity Tech hit with investor class action after shares drop 49.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619635414","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619635414?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:41","pubTimestamp":1773664877,"startTime":"0","endTime":"0","summary":"Berger Montague filed a securities class action against Oddity on behalf of investors who bought shares between Feb. 26, 2025 and Feb. 24, 2026. The complaint alleges the company misled investors about its digital operating model and did not disclose risks tied to an algorithm change at its largest advertising partner. Oddity disclosed an advertising “dislocation” linked to algorithm changes and said it expected first-quarter 2026 revenue to decline about 30% year over year. Following that disclosure, the company’s Class A share price fell 49.21% to $14.74.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL1ZV5Gd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014039.USD","NDAQ","IE00BN0W2T93.GBP","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4588","BK4585","IE0009354923.USD","LU2210149790.SGD","ODD","SG9999014021.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618131077","title":"Oddity Tech board approves USD 200 million share buyback plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131077","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131077?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:08","pubTimestamp":1773317325,"startTime":"0","endTime":"0","summary":"Oddity said its board approved a share buyback program authorizing repurchases of up to USD 200 million of its Class A ordinary shares. The company said the new program replaces and supersedes its prior USD 150 million buyback plan and expires on March 31, 2029. Oddity said it had repurchased about USD 97 million under the prior authorization, including about USD 50 million year-to-date. The company said repurchases may be conducted in the open market, including under Rule 10b5-1 trading plans, or in privately negotiated transactions. Oddity said the program does not obligate it to repurchase any specific number of shares and may be suspended, modified, or discontinued at any time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDLbBsJbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618131439","title":"Oddity Tech Announces $200M Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131439","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131439?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA8CL1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://oddity.com","stockEarnings":[{"period":"1week","weight":-0.0339},{"period":"1month","weight":0.0885},{"period":"3month","weight":-0.6665},{"period":"6month","weight":-0.774},{"period":"1year","weight":-0.7024},{"period":"ytd","weight":-0.6665}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0454},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.168},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.","exchange":"NASDAQ","name":"ODDITY Tech Ltd.","nameEN":"ODDITY Tech Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ODDITY Tech Ltd.,ODD,ODDITY Tech Ltd.股票,ODDITY Tech Ltd.股票老虎,ODDITY Tech Ltd.股票老虎国际,ODDITY Tech Ltd.行情,ODDITY Tech Ltd.股票行情,ODDITY Tech Ltd.股价,ODDITY Tech Ltd.股市,ODDITY Tech Ltd.股票价格,ODDITY Tech Ltd.股票交易,ODDITY Tech Ltd.股票购买,ODDITY Tech Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}